Page 3 - Dan Longo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The New England Journal of Medicine yesterday published two studies on the effectiveness of the interleukin-6 receptor antagonists tocilizumab and sarilumab in severely ill adult COVID-19 patients, one finding a benefit to a combination of the two drugs and the other showing no benefit with tocilizumab alone. Early treatment with combo may be key The first study, led by researchers at Imperial College London as part of an ongoing international platform trial, involved randomly assigning 803 patients in 113 intensive care units (ICUs) in six countries to receive tocilizumab, sarilumab, or usu...

Word Count: 862 A Food and Drug Administration advisory panel gathered Thursday to consider issues including the safety of the shot from Pfizer Inc. and BioNTech SE, which employs a technology called messenger RNA that’s never before been used in human vaccines. The government is prepared with a safety monitoring system that will go into place the first day of the immunization campaign, said Nancy Messonnier, director of the Centers for Disease Control and Prevention’s National Center for Immunization and Respiratory Diseases. “Vaccine safety and effective monitoring are a top priority ...

BioPharma